skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines vandetanibQuestion & answer

vandetanib · Medicine question

Has fatal interstitial lung disease been reported with vandetanib?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, interstitial lung disease has been observed in patients receiving vandetanib, and some cases have been fatal.

Sources for this answer

Caprelsa 300 mg film-coated tabletsSANOFI · emc · SmPC §4.4 Special warnings and precautions for use · Version 9Document updated 25 March 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about vandetanib

Which potentially life-threatening severe skin reactions have been reported with vandetanib?Can vandetanib cause heart failure?Is concomitant use of vandetanib and ondansetron recommended?Should concomitant use of vandetanib and St John's wort be avoided?How does vandetanib affect metformin exposure?What is the minimum approved age for vandetanib (Caprelsa) treatment?

vandetanib

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the vandetanib guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX